Poland· PL-100406609
Ylpio
A telmisartan und diuretika product containing telmisartanum + indapamidum, registered in Poland by PRO.MED.CS Praha a.s.. The same ATC class is registered in 13 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Telmisartan und diuretika is registered in 13 of 19 countries.
Countries holding a registration under ATC C09DA07 (telmisartan und diuretika), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Telmisartan und diuretika · ATC C09DA07
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Telmisartanum + Indapamidum
- Manufacturer
- PRO.MED.CS Praha a.s.
- Country
- Poland (PL)
- ATC code
- C09DA07
- ATC class
- Telmisartan und Diuretika
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
1 priced- gtin0590999146355730 szt.PLN 30.19
- gtin05909991463564
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
80 interactions on record for telmisartan und diuretika.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Telmisartan und diuretika · interactions on record
80 records
80 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Telmisartan und diuretika in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTELMISARTAN/INDAPAMID PMCSPRO.MED.CS Praha a.s.
- GermanyTelmicor-IndaKrka, D.D., Novo Mesto
- FinlandYlpioPro.Med.Cs Praha a.s.
- NetherlandsYLPIO 80 mg/2,5 mg tablettenPRO.MED.CS Praha a.s.
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Belgium · Ylpio
- Bulgaria · Толмидуо
- Cyprus · Tolmiduo
- Czechia · Tedenomo, Telmisartan/Indapamid Pmcs
- Germany · Telmicor-Inda, Telmiinda Apontis
- Estonia · Tolurindo
- Finland · Ylpio
- Croatia · Tolurindo
- Hungary · Tedenomo, Telmisartan/Indapamid Krka
- Lithuania · Ilpio, Tolmiduo
- Luxembourg · Ylpio
- Latvia · Ilpio, Tolurindo
- Netherlands · Ylpio
- Portugal · Tolurindo
- Romania · Tolmiduo, Ylpio
- Slovenia · Tolupind
- Slovakia · Tolupind, Ylpio
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c6a70f55-7dfd-4db6-990f-78ddae11f145 GET /v1/drugs/c6a70f55-7dfd-4db6-990f-78ddae11f145?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "80 mg + 2,5 mg",
"packaging": "05909991463557 ¦ Rp ¦ 141650\n30 tabl.\n05909991463564 ¦ Rp ¦ 141651\n100 tabl.",
"substance": "Telmisartanum 80 mg + Indapamidum 2.5 mg",
"common_name": "Telmisartanum + Indapamidum",
"pl_product_id": "100406609",
"pozwolenie_nr": "26597",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about telmisartan und diuretika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.